Calidi Biotherapeutics Inc (CLDI)
2.025
-1.36
(-40.09%)
USD |
NYAM |
Nov 14, 16:00
2.05
+0.02
(+1.23%)
After-Hours: 20:00
Calidi Biotherapeutics Enterprise Value: 31.40M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 31.40M |
| November 12, 2024 | 21.13M |
| November 11, 2024 | 17.57M |
| November 08, 2024 | 17.65M |
| November 07, 2024 | 16.60M |
| November 06, 2024 | 15.79M |
| November 05, 2024 | 15.39M |
| November 04, 2024 | 14.74M |
| November 01, 2024 | 14.99M |
| October 31, 2024 | 13.61M |
| October 30, 2024 | 13.05M |
| October 29, 2024 | 12.80M |
| October 28, 2024 | 13.61M |
| October 25, 2024 | 12.88M |
| October 24, 2024 | 10.86M |
| October 23, 2024 | 10.78M |
| October 22, 2024 | 13.21M |
| October 21, 2024 | 13.21M |
| October 18, 2024 | 13.93M |
| October 17, 2024 | 13.69M |
| October 16, 2024 | 13.69M |
| October 15, 2024 | 12.56M |
| October 14, 2024 | 12.50M |
| October 11, 2024 | 12.64M |
| October 10, 2024 | 12.41M |
| Date | Value |
|---|---|
| October 09, 2024 | 12.24M |
| October 08, 2024 | 12.80M |
| October 07, 2024 | 12.40M |
| October 04, 2024 | 12.64M |
| October 03, 2024 | 12.80M |
| October 02, 2024 | 12.96M |
| October 01, 2024 | 12.88M |
| September 30, 2024 | 13.29M |
| September 27, 2024 | 13.85M |
| September 26, 2024 | 13.85M |
| September 25, 2024 | 13.37M |
| September 24, 2024 | 13.61M |
| September 23, 2024 | 13.05M |
| September 20, 2024 | 12.88M |
| September 19, 2024 | 13.00M |
| September 18, 2024 | 13.05M |
| September 17, 2024 | 13.51M |
| September 16, 2024 | 13.61M |
| September 13, 2024 | 13.45M |
| September 12, 2024 | 13.45M |
| September 11, 2024 | 13.77M |
| September 10, 2024 | 13.45M |
| September 09, 2024 | 13.37M |
| September 06, 2024 | 13.41M |
| September 05, 2024 | 13.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.78M
Minimum
Oct 23 2024
183.39M
Maximum
Sep 13 2023
37.09M
Average
20.77M
Median
Enterprise Value Benchmarks
| Lumos Pharma Inc | 23.67M |
| NovaBay Pharmaceuticals Inc | 2.762M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.767M |
| Total Expenses (Quarterly) | 5.591M |
| EPS Diluted (Quarterly) | -14.00 |
| Earnings Yield | -973.7% |